Stay updated on LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial
Sign up to get notified when there's something new on the LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial page.

Latest updates to the LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This appears to be a behind-the-scenes site update with no user-facing content changes.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe History page shows a new entry Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2; these are minor site-level updates and do not impact trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page history shows a new revision (v3.3.2) added and a previous revision (v3.2.0) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe global operating-status notice shown at the top of the page was removed. This change does not affect the displayed trial details or navigation on the record history page.SummaryDifference0.8%

- Check84 days agoChange DetectedNo additions or deletions were detected in the page history for NCT04790513.SummaryDifference0.1%

- Check105 days agoChange Detected- Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.SummaryDifference13%

Stay in the know with updates to LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial page.